| Medical and Health Sciences | Lifetime | 375 | US 204 | 99.98 |
| Cardiology and Cardiovascular Medicine | Lifetime | 34 | US 24 | 99.97 |
| Surgery | Lifetime | 795 | US 426 | 99.26 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 400 | US 222 | 98.80 |
| Nephrology | Lifetime | 617 | US 293 | 92.60 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 162 | US 80 | 99.16 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 512 | US 200 | 83.27 |
| Cardiovascular Function and Risk Factors | Lifetime | 9 | US 8 | 99.97 |
| Heart Failure Treatment and Management | Lifetime | 14 | US 9 | 99.94 |
| Cardiac Structural Anomalies and Repair | Lifetime | 94 | US 65 | 99.64 |
| Blood Pressure and Hypertension Studies | Lifetime | 130 | US 58 | 99.50 |
| Cardiac pacing and defibrillation studies | Lifetime | 120 | US 66 | 99.54 |
| Hormonal Regulation and Hypertension | Lifetime | 116 | US 50 | 99.33 |
| Potassium and Related Disorders | Lifetime | 25 | US 16 | 99.42 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 281 | US 154 | 99.18 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 347 | US 171 | 99.02 |
| Cardiac Imaging and Diagnostics | Lifetime | 420 | US 225 | 99.30 |
| Lipoproteins and Cardiovascular Health | Lifetime | 189 | US 99 | 99.10 |
| Acute Myocardial Infarction Research | Lifetime | 216 | US 118 | 99.30 |
| Diabetes Treatment and Management | Lifetime | 300 | US 124 | 98.82 |
| Heart Rate Variability and Autonomic Control | Lifetime | 675 | US 306 | 97.91 |
| Renin-Angiotensin System Studies | Lifetime | 278 | US 118 | 97.16 |
| Cardiac Fibrosis and Remodeling | Lifetime | 236 | US 93 | 96.53 |
| Chronic Kidney Disease and Diabetes | Lifetime | 539 | US 220 | 97.19 |
| Cardiovascular Health and Disease Prevention | Lifetime | 823 | US 312 | 96.60 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 939 | US 323 | 96.19 |
| Pharmaceutical Economics and Policy | Lifetime | 733 | US 317 | 92.84 |
| Heart rate and cardiovascular health | Lifetime | 275 | US 91 | 85.35 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 125 | US 59 | 99.13 |
| Heart Failure Treatment and Management | 2021-2025 | 84 | US 38 | 99.05 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 826 | US 270 | 93.76 |
| Potassium and Related Disorders | 2021-2025 | 87 | US 35 | 92.46 |
| Hormonal Regulation and Hypertension | 2021-2025 | 980 | US 210 | 78.42 |
| Electrolyte and hormonal disorders | 2021-2025 | 427 | US 119 | 74.15 |
| Advanced Causal Inference Techniques | 2021-2025 | 775 | US 406 | 58.87 |
